Susanna Naggie, MD

Publications

Kleinstein, SE, Shea, PR, Stamm, LM, Sulkowski, M, Goldstein, DB, and Naggie, S. "Association of CYP2B6 Single-Nucleotide Polymorphisms Altering Efavirenz Metabolism With Hepatitis C Virus (HCV) Treatment Relapse Among Human Immunodeficiency Virus/HCV-Coinfected African Americans Receiving Ledipasvir/Sofosbuvir in the ION-4 Trial." Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America (March 7, 2018).

PMID
29522085
Full Text

Okeke, NL, Craig, DM, Muehlbauer, MJ, Ilkayeva, O, Clement, ME, Naggie, S, and Shah, SH. "Metabolites predict cardiovascular disease events in persons living with HIV: a pilot case–control study." Metabolomics 14, no. 3 (March 1, 2018).

Full Text

Clement, ME, Lin, L, Navar, AM, Okeke, NL, Naggie, S, and Douglas, PS. "Lower likelihood of cardiac procedures after acute coronary syndrome in patients with human immunodeficiency virus/acquired immunodeficiency syndrome." Medicine 97, no. 6 (February 2018): e9849-.

PMID
29419696
Full Text

Collins, LF, Chan, A, Zheng, J, Chow, S-C, Wilder, JM, Muir, AJ, and Naggie, S. "Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection." Open forum infectious diseases 5, no. 1 (January 2018): ofx264-.

PMID
29308413
Full Text

Morgan, JR, Kim, AY, Naggie, S, and Linas, BP. "The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets." Open forum infectious diseases 5, no. 1 (January 2018): ofx267-.

PMID
29354660
Full Text

Lok, AS, Chung, RT, Vargas, HE, Kim, AY, Naggie, S, and Powderly, WG. "Benefits of direct-acting antivirals for Hepatitis C." Annals of Internal Medicine 167, no. 11 (December 5, 2017): 812-813.

Full Text

Powderly, WG, Naggie, S, Kim, AY, Vargas, HE, Chung, RT, and Lok, AS. "IDSA/AASLD Response to Cochrane Review on Direct-Acting Antivirals for Hepatitis C." CLINICAL INFECTIOUS DISEASES 65, no. 11 (December 1, 2017): 1773-1775.

Full Text

Lok, AS, Chung, RT, Vargas, HE, Kim, AY, Naggie, S, and Powderly, WG. "Benefits of Direct-Acting Antivirals for Hepatitis C." Annals of internal medicine 167, no. 11 (December 2017): 812-813.

PMID
29049502
Full Text

Zuckerman, A, Chastain, CA, and Naggie, S. "Retreatment Options Following HCV Direct Acting Antiviral Failure." Current treatment options in infectious diseases 9, no. 4 (December 2017): 389-402.

PMID
29242710
Full Text

Carlton-Smith, C, Holmes, JA, Naggie, S, Lidofsky, A, Lauer, GM, Kim, AY, Chung, RT, and of the ACTG A5327 study group, . "IFN-free therapy is associated with restoration of type I IFN response in HIV-1 patients with acute HCV infection who achieve SVR." Journal of viral hepatitis (November 29, 2017).

PMID
29193564
Full Text

Pages